DNA Mouthwash, Revisited

DNA Mouthwash, Revisited I just noticed a reader's letter1 that was critical of your article on the DNA Mouthwash.2 The letter writer works for a clinical research center at a university hospital in Utah. He is not a forensic scientist and is apparently not familiar with the saliva-vs.-blood issue in the forensic community. First, the safety issue (HIV, hepatitis C, etc.) is driving crime labs away from the use of blood draws. Second, the issue of quantity of DNA recovered from saliva vs. b

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I just noticed a reader's letter1 that was critical of your article on the DNA Mouthwash.2 The letter writer works for a clinical research center at a university hospital in Utah. He is not a forensic scientist and is apparently not familiar with the saliva-vs.-blood issue in the forensic community. First, the safety issue (HIV, hepatitis C, etc.) is driving crime labs away from the use of blood draws. Second, the issue of quantity of DNA recovered from saliva vs. blood is really a nonissue, because both methods provide more than enough DNA for dozens to hundreds of genetic assays. Third, even with preservatives, DNA degradation in liquid blood is not uncommon in samples that have been sitting around for extended periods of time.

When dealing with forensic samples, it may be days to weeks before the material can be tested. As a result, forensic labs often get better results ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Phillip Danielson

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide